# ğŸ“Š Project Presentation

> Comprehensive slide deck covering the end-to-end ICU 30-Day Readmission Risk Prediction project â€” from raw clinical data to a live deployed application.

---

## ğŸ“¥ View Presentation

**ğŸ‘‰ [ICU_Readmission_Presentation.pdf](ICU_Readmission_Presentation.pdf)**

*Click the link above â€” GitHub will render the PDF directly in your browser. No download needed.*

---

## ğŸ¯ At a Glance

| Detail | Info |
|--------|------|
| **Topic** | ICU 30-Day Readmission Risk Prediction |
| **Dataset** | MIMIC-IV v2.2 (48,676 patients) |
| **Model Performance** | AUC-ROC: 0.7884 on held-out test set |
| **Audience** | Data science hiring managers, healthcare analytics teams, ML engineers |
| **Duration** | ~15â€“20 minutes |
| **Format** | PDF (converted from PowerPoint) |

---

## ğŸ“‹ Slide Breakdown

### ğŸ”´ Section 1 â€” Problem & Clinical Background *(Slides 1â€“3)*
- Why ICU readmissions matter clinically and financially
- Current gaps in predictive tools
- Project goals and success criteria

### ğŸŸ¡ Section 2 â€” Data & Methodology *(Slides 4â€“6)*
- MIMIC-IV dataset overview (48,676 patients, 225+ features)
- SQL-based data extraction pipeline (6,303 lines of BigQuery SQL)
- Feature engineering across 7 clinical domains

### ğŸŸ¢ Section 3 â€” Model Development *(Slides 7â€“10)*
- Baseline models evaluated: Logistic Regression, Random Forest, XGBoost, LightGBM
- Hyperparameter tuning with Optuna (40 trials)
- Model selection rationale and cross-validation strategy

### ğŸ”µ Section 4 â€” Results *(Slides 11â€“14)*
- Test set performance: **AUC-ROC 0.7884**
- Benchmarked against 6 published MIMIC-IV studies
- SHAP-based feature importance and clinical interpretability
- Missingness analysis (MNAR detection)

### ğŸŸ£ Section 5 â€” Deployment *(Slides 15â€“17)*
- Streamlit app architecture
- Live risk calculator interface walkthrough
- Clinical recommendation engine design

### âš« Section 6 â€” Impact & Next Steps *(Slides 18â€“20)*
- Potential clinical use cases
- Limitations and ethical considerations
- Future work and improvements

---

## ğŸ† Key Takeaways

1. **End-to-End Ownership** â€” SQL extraction â†’ Python modeling â†’ Streamlit deployment
2. **Production-Grade Engineering** â€” 6,303 lines of SQL with 6 quality checks
3. **Clinical Validity** â€” Evidence-based features, MNAR analysis, clinically meaningful thresholds
4. **Strong Performance** â€” 0.7884 AUC-ROC, competitive with published literature
5. **Live Demo** â€” Deployed on Streamlit Cloud, accessible to anyone

---

## ğŸ”— Related Links

| Resource | Link |
|----------|------|
| ğŸš€ Live Streamlit App | [Launch App](https://your-app-name.streamlit.app) |
| ğŸ—„ï¸ SQL Queries | [View SQL â†’](../../sql/) |
| ğŸ““ Analysis Notebook | [View Notebook â†’](../../notebooks/) |
| ğŸ“„ Results Summary | [View Results â†’](../RESULTS_SUMMARY.md) |
| ğŸ“„ Data Access Guide | [View Data Statement â†’](../DATA_STATEMENT.md) |
| ğŸ  Main Repository | [Back to README â†’](../../README.md) |

---

*Questions? Open a GitHub Issue or contact: your.email@example.com*
